Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bingley, P. J.
Right arrow Articles by Mueller, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bingley, P. J.
Right arrow Articles by Mueller, P. W.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 52:1128-1136, 2003
© 2003 by the American Diabetes Association, Inc.

Diabetes Antibody Standardization Program: First Assay Proficiency Evaluation

Polly J. Bingley1, Ezio Bonifacio2, and Patricia W. Mueller3 Participating Laboratories

1 Division of Medicine, University of Bristol, Bristol, U.K.
2 Istitutio Scientifico San Raffaele, Milan, Italy
3 Centers for Disease Control and Prevention, Atlanta, Georgia

The aims of the first proficiency evaluation of the Diabetes Antibody Standardization Program (DASP) were to assess general implementation of assay methods and to evaluate the new World Health Organization (WHO) reference reagent for autoantibodies to GAD and IA-2. Forty-six laboratories in 13 countries received coded sera from 50 patients with newly diagnosed type 1 diabetes and 50 blood donor control subjects, together with the WHO reference reagent and diluent serum. Results were analyzed using receiver operator characteristic (ROC) curves. Sensitivity was adjusted to 90% specificity in workshop controls. The median adjusted sensitivity for GADA (45 laboratories) was 84% (range 62–96%), for IA-2A (43 laboratories) was 58% (50–74%), and for insulin autoantibody (IAA; 23 laboratories) was 36% (13–66%). ROC curve analysis showed all GADA and IA-2A assays, and 18/23 IAA assays found significant differences between patients and control subjects. There was good concordance between laboratories in ranking of samples by GADA and IA-2A levels or if results were expressed in relation to the WHO reference reagent. Assays that achieved the highest sensitivity for IAA were also concordant in ranking samples, but overall concordance for IAA was poor. Differences in assay protocols between laboratories must be addressed so that all centers and kit manufacturers can perform to the same high standard.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
C. Tiberti, C. Giordano, M. Locatelli, E. Bosi, G. F. Bottazzo, R. Buzzetti, D. Cucinotta, A. Galluzzo, A. Falorni, and F. Dotta
Identification of Tyrosine Phosphatase 2(256-760) Construct as a New, Sensitive Marker for the Detection of Islet Autoimmunity in Type 2 Diabetic Patients: The Non-Insulin Requiring Autoimmune Diabetes (NIRAD) Study 2
Diabetes, May 1, 2008; 57(5): 1276 - 1283.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. Martinuzzi, G. Novelli, M. Scotto, P. Blancou, J.-M. Bach, L. Chaillous, G. Bruno, L. Chatenoud, P. van Endert, and R. Mallone
The Frequency and Immunodominance of Islet-Specific CD8+ T-cell Responses Change after Type 1 Diabetes Diagnosis and Treatment
Diabetes, May 1, 2008; 57(5): 1312 - 1320.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. Buzzetti, A. Petrone, M. Capizzi, E. Bosi, and for the Non Insulin Requiring Autoimmune Diabetes
High Titer of Autoantibodies to GAD Identifies a Specific Phenotype of Adult-Onset Autoimmune Diabetes: Response to Kobayashi et al.
Diabetes Care, November 1, 2007; 30(11): e127 - e127.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. M. Wenzlau, K. Juhl, L. Yu, O. Moua, S. A. Sarkar, P. Gottlieb, M. Rewers, G. S. Eisenbarth, J. Jensen, H. W. Davidson, et al.
The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes
PNAS, October 23, 2007; 104(43): 17040 - 17045.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
S. E. Fineberg, T. T. Kawabata, D. Finco-Kent, R. J. Fountaine, G. L. Finch, and A. S. Krasner
Immunological Responses to Exogenous Insulin
Endocr. Rev., October 1, 2007; 28(6): 625 - 652.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
C. Nilsson, D. Ursing, C. Torn, A. Aberg, and M. Landin-Olsson
Presence of GAD Antibodies During Gestational Diabetes Mellitus Predicts Type 1 Diabetes
Diabetes Care, August 1, 2007; 30(8): 1968 - 1971.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Goel, H. Chiu, J. Felton, J. P. Palmer, and B. Brooks-Worrell
T-Cell Responses to Islet Antigens Improves Detection of Autoimmune Diabetes and Identifies Patients With More Severe {beta}-Cell Lesions in Phenotypic Type 2 Diabetes
Diabetes, August 1, 2007; 56(8): 2110 - 2115.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
A Mayer, N Fabien, M C Gutowski, V Dubois, L Gebuhrer, J Bienvenu, J Orgiazzi, and A M Madec
Contrasting cellular and humoral autoimmunity associated with latent autoimmune diabetes in adults
Eur. J. Endocrinol., July 1, 2007; 157(1): 53 - 61.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Blancou, R. Mallone, E. Martinuzzi, S. Severe, S. Pogu, G. Novelli, G. Bruno, B. Charbonnel, M. Dolz, L. Chaillous, et al.
Immunization of HLA Class I Transgenic Mice Identifies Autoantigenic Epitopes Eliciting Dominant Responses in Type 1 Diabetes Patients
J. Immunol., June 1, 2007; 178(11): 7458 - 7466.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. Buzzetti, S. Di Pietro, A. Giaccari, A. Petrone, M. Locatelli, C. Suraci, M. Capizzi, M. L. Arpi, E. Bazzigaluppi, F. Dotta, et al.
High Titer of Autoantibodies to GAD Identifies a Specific Phenotype of Adult-Onset Autoimmune Diabetes
Diabetes Care, April 1, 2007; 30(4): 932 - 938.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Mallone, E. Martinuzzi, P. Blancou, G. Novelli, G. Afonso, M. Dolz, G. Bruno, L. Chaillous, L. Chatenoud, J.-M. Bach, et al.
CD8+ T-Cell Responses Identify {beta}-Cell Autoimmunity in Human Type 1 Diabetes
Diabetes, March 1, 2007; 56(3): 613 - 621.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
V. Seyfert-Margolis, T. D. Gisler, A. L. Asare, R. S. Wang, H. M. Dosch, B. Brooks-Worrell, G. S. Eisenbarth, J. P. Palmer, C. J. Greenbaum, S. E. Gitelman, et al.
Analysis of T-Cell Assays to Measure Autoimmune Responses in Subjects With Type 1 Diabetes: Results of a Blinded Controlled Study
Diabetes, September 1, 2006; 55(9): 2588 - 2594.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Barinas-Mitchell, L. H. Kuller, S. Pietropaolo, Y.-J. Zhang, T. Henderson, and M. Pietropaolo
The Prevalence of the 65-Kilodalton Isoform of Glutamic Acid Decarboxylase Autoantibodies by Glucose Tolerance Status in Elderly Patients from the Cardiovascular Health Study
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2871 - 2877.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
K. M. Gillespie
Type 1 diabetes: pathogenesis and prevention.
Can. Med. Assoc. J., July 18, 2006; 175(2): 165 - 170.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
T Reinehr, E Schober, S Wiegand, A Thon, R Holl, and on behalf of the DPV-Wiss Study Group
{beta}-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification?
Arch. Dis. Child., June 1, 2006; 91(6): 473 - 477.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Sapone, L. de Magistris, M. Pietzak, M. G. Clemente, A. Tripathi, F. Cucca, R. Lampis, D. Kryszak, M. Carteni, M. Generoso, et al.
Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives.
Diabetes, May 1, 2006; 55(5): 1443 - 1449.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
S Genovese, E Bazzigaluppi, D Goncalves, A Ciucci, M G Cavallo, F Purrello, M Anello, C M Rotella, G Bardini, O Vaccaro, et al.
Clinical phenotype and {beta}-cell autoimmunity in Italian patients with adult-onset diabetes.
Eur. J. Endocrinol., March 1, 2006; 154(3): 441 - 447.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Pihoker, L. K. Gilliam, C. S. Hampe, and A. Lernmark
Autoantibodies in Diabetes
Diabetes, December 1, 2005; 54(suppl_2): S52 - S61.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
G. Bruno, C. Runzo, P. Cavallo-Perin, F. Merletti, M. Rivetti, S. Pinach, G. Novelli, M. Trovati, F. Cerutti, G. Pagano, et al.
Incidence of Type 1 and Type 2 Diabetes in Adults Aged 30-49 Years: The population-based registry in the province of Turin, Italy
Diabetes Care, November 1, 2005; 28(11): 2613 - 2619.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
G. Bruno, F. Cerutti, F. Merletti, P. Cavallo-Perin, E. Gandolfo, M. Rivetti, C. Runzo, S. Pinach, G. Pagano, and The Piedmont Study Group for Diabetes Epidemiology
Residual {beta}-Cell Function and Male/Female Ratio Are Higher in Incident Young Adults Than in Children: The registry of type 1 diabetes of the province of Turin, Italy, 1984-2000
Diabetes Care, February 1, 2005; 28(2): 312 - 317.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. Zinman, S. E. Kahn, S. M. Haffner, M. C. O'Neill, M. A. Heise, M. I. Freed, and ADOPT Study Group*
Phenotypic Characteristics of GAD Antibody-Positive Recently Diagnosed Patients With Type 2 Diabetes in North America and Europe
Diabetes, December 1, 2004; 53(12): 3193 - 3200.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Maioli, E. Alejandro, G. Tonolo, L. K. Gilliam, L. Bekris, C. S. Hampe, D. A. Obinu, A. Manconi, L. Puddu, K. Lynch, et al.
Epitope-Restricted 65-Kilodalton Glutamic Acid Decarboxylase Autoantibodies among New-Onset Sardinian Type 2 Diabetes Patients Define Phenotypes of Autoimmune Diabetes
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5675 - 5682.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. Tanaka, T. Endo, K. Aida, H. Shimura, N. Yokomori, M. Kaneshige, F. Furuya, S. Amemiya, M. Mochizuki, K. Nakanishi, et al.
Distinct Diagnostic Criteria of Fulminant Type 1 Diabetes Based on Serum C-Peptide Response and HbA1c Levels at Onset
Diabetes Care, August 1, 2004; 27(8): 1936 - 1941.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
X. Palomer, D. Mauricio, J. Rodriguez-Espinosa, E. Zapico, C. Mayoral, F. Gonzalez-Sastre, A. de Leiva, and F. Blanco-Vaca
Evaluation of Two Nonisotopic Immunoassays for Determination of Glutamic Acid Decarboxylase and Tyrosine Phosphatase Autoantibodies in Serum
Clin. Chem., August 1, 2004; 50(8): 1378 - 1382.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
M. Hummel, E. Bonifacio, S. Schmid, M. Walter, A. Knopff, and A.-G Ziegler
Brief Communication: Early Appearance of Islet Autoantibodies Predicts Childhood Type 1 Diabetes in Offspring of Diabetic Parents
Ann Intern Med, June 1, 2004; 140(11): 882 - 886.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. M. Brooks-Worrell, C. J. Greenbaum, J. P. Palmer, and C. Pihoker
Autoimmunity to Islet Proteins in Children Diagnosed with New-Onset Diabetes
J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2222 - 2227.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. Barinas-Mitchell, S. Pietropaolo, Y.-J. Zhang, T. Henderson, M. Trucco, L. H. Kuller, and M. Pietropaolo
Islet Cell Autoimmunity in a Triethnic Adult Population of the Third National Health and Nutrition Examination Survey
Diabetes, May 1, 2004; 53(5): 1293 - 1302.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Kukko, S. M. Virtanen, A. Toivonen, S. Simell, S. Korhonen, J. Ilonen, O. Simel, and M. Knip
Geographical Variation in Risk HLA-DQB1 Genotypes for Type 1 Diabetes and Signs of {beta}-Cell Autoimmunity in a High-Incidence Country
Diabetes Care, March 1, 2004; 27(3): 676 - 681.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Achenbach, K. Warncke, J. Reiter, H. E. Naserke, A. J.K. Williams, P. J. Bingley, E. Bonifacio, and A.-G. Ziegler
Stratification of Type 1 Diabetes Risk on the Basis of Islet Autoantibody Characteristics
Diabetes, February 1, 2004; 53(2): 384 - 392.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. Koczwara, E. Bonifacio, and A.-G. Ziegler
Transmission of Maternal Islet Antibodies and Risk of Autoimmune Diabetes in Offspring of Mothers With Type 1 Diabetes
Diabetes, January 1, 2004; 53(1): 1 - 4.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. McKinney, H. Cao, M. T. Behme, J. L. Mahon, and R. A. Hegele
Maturity-Onset Diabetes of the Young (MODY) Mutation in Type 2 Diabetes and Latent Autoimmune Diabetes of the Adult
Diabetes Care, December 1, 2003; 26(12): 3358 - 3359.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. E. Kitabchi
Ketosis-Prone Diabetes--A New Subgroup of Patients with Atypical Type 1 and Type 2 Diabetes?
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5087 - 5089.
[Full Text] [PDF]


Home page
Diabetes CareHome page
T. Ota, T. Takamura, Y. Bando, R. Usuda, and Y. Nagai
Predictive Value of Autoantibodies to IA-2 for Insulin Requirements in Japanese Subjects With Type 1 Diabetes
Diabetes Care, November 1, 2003; 26(11): 3188 - 3189.
[Full Text] [PDF]


Home page
JAMAHome page
A.-G. Ziegler, S. Schmid, D. Huber, M. Hummel, and E. Bonifacio
Early Infant Feeding and Risk of Developing Type 1 Diabetes-Associated Autoantibodies
JAMA, October 1, 2003; 290(13): 1721 - 1728.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2003 by the American Diabetes Association.